The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

In today’s ACT Brief, we explore how Bayesian trial designs are gaining traction in rare disease research, what priorities clinical operations leaders should focus on in 2026, and how rare disease ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

Saria is director of the Johns Hopkins Machine Learning and Healthcare Lab. Bayesian's technology, which received an FDA ...

A new study introduces a global probabilistic forecasting model that predicts when and where ionospheric disturbances—measured by the Rate of total electron content (TEC) Index (ROTI)—are likely to ...